French CRO Novasep bulks up its manufacturing services in the U.S.

French contract drug developer Novasep is investing in its U.S. operation, planning to build a new lab in Pennsylvania that will bolster its manufacturing business.

Fox Foundation backs Evotec's Parkinson's project

The Michael J. Fox Foundation awarded a grant to Evotec to support the company's work in Parkinson's disease, bankrolling a project meant to clear the way for new therapies.

Catalent invests more in Asia, beefing up a Singapore supply outpost

Catalent Pharma Solutions is building up its clinical supply capabilities in Asia, expanding a Singapore facility as it works on a sizable expansion in Japan.

Onyx Scientific expands again as GMP demand grows

Onyx Scientific is set to increase the size of its U.K.-based site by more than 30% as it enjoys the spoils of a lucrative 2015.

BioClinica launches new research offering for marketed meds

Princeton, NJ-based BioClinica is looking to take big steps into the growing realm of helping biopharma with data and costs after launch as it unveils a new division focused on postapproval studies.

PRA recruits a U.K. marketing firm to help it reach more patients

PRA Health Sciences recruited a healthcare marketing firm with the goal of refining its pitch to potential trial participants and improving recruitment.

Icon launches new tech with promise to simplify adaptive trials

CRO giant Icon has expanded its technology portfolio with a system it says can improve patient randomization and clinical supply in adaptive trials.

Parexel dims its revenue expectations despite a solid quarter

Parexel lowered its fiscal-year revenue projections by about 2% despite posting modest growth in the last quarter, working through a sizable restructuring program designed to boost profits.

In the midst of cuts, Parexel signs new research deal

CRO giant Parexel has inked a new pact with the Optum Life Sciences unit of the nation's largest insurer, UnitedHealth Group, to help lower costs in postapproval studies.

BioClinica notches up another deal, this time with EPS

BioClinica's appetite for pacts shows no sign of abating as it announces a new tie-up with Japanese CRO EPS to focus on risk-based monitoring in clinical trials.

Spotlight On... India hopes for a clinical trial upswing; Pierre Fabre taps BioAscent for compound management; and much more...

India's Council of Medical Research is pushing for a renewed emphasis on clinical trials in the country, hoping to reverse a downturn spurred by tightened regulations and safety concerns. The...

French CRO Biotrial tries to move forward after disastrous clinical study

Biotrial, the CRO that ran a Phase I study that proved deadly, said it's working with authorities to piece together what went wrong while trying to move its business forward.

Biosimilars developer Celltrion taps Medidata for trial tech

South Korea's Celltrion has recruited Medidata to provide eClinical technology as it works to develop copycat versions of the world's top-selling biological treatments.

Catalent extends its clinical supply biz into Japan

Catalent Pharma Solutions is upgrading a Japanese plant to offer clinical supply services, extending its global network of depots.

Parexel moves to buy a pharma consulting firm

CRO Parexel International is buying a 120-employee consulting firm headquartered in Boston, focusing on market access and commercialization.

BioClinica buys into cost management with its latest deal

Acquisitive CRO BioClinica bought a firm that specializes in handling the financial side of clinical trials, picking up technology that automates how sponsors and contractors pay for studies.

Spotlight On... inVentiv opens new Phase I clinic; Pfizer taps Adaptive for immunotherapy R&D; and much more...

CRO inVentiv Health is expanding its early-stage research capabilities, opening a new Phase I clinic in Florida. The facility, sited at the University of Miami Life Science and Technology Park, has...

Evotec hits an R&D milestone with J&J in an ambitious Alzheimer's collaboration

Risk-sharing researcher Evotec said it's advancing an early-stage Alzheimer's disease project alongside partner Johnson & Johnson, working to find new approaches to treating the neurodegenerative disorder.

Eurofins buys Dutch drug-testing firm to pad its services

Luxembourg testing outfit Eurofins is deepening its work in biopharma, acquiring a specialist in drug testing headquartered in the Netherlands.

AMRI signs a trio of deals in R&D, manufacturing and marketing

Contract drug developer AMRI bolstered its client roster with three new agreements making use of its R&D, manufacturing and marketing divisions.